Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PULSE BIOSCIENCES, INC. Director's Dealing 2019

Mar 19, 2019

32093_dirs_2019-03-19_1463f598-62f4-4e43-a7be-034d5d64a813.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2019-03-18

Reporting Person: Levinson Mitchell E. (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-03-18 Stock Option (right to buy) $18.25 A 35000 Acquired 2029-03-18 Common Stock (35000) Direct

Footnotes

F1: One-third (1/3) of the shares subject to the option will vest on the one-year anniversary of the grant date, and the remaining shares will vest monthly over the following two years, subject to the Reporting Person's continued service through each vesting date.